Precision radiation may slow rare salivary gland cancer
NCT ID NCT04883671
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether giving focused radiation (SBRT) early to people with adenoid cystic carcinoma that has spread to a few spots can slow the cancer's growth. About 32 participants will either receive SBRT or standard care. Researchers will track how long the cancer stays under control and how patients feel.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stereotactic body radiation therapy (SBRT)
- What this could lead to
- If it works, this could offer a way to delay cancer progression and improve quality of life for people with advanced adenoid cystic carcinoma.
- What could go wrong
- This is a small, early-phase trial with only 32 participants, so results may not apply to everyone. SBRT can cause side effects like fatigue or damage to nearby organs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
Contact Email: •••••@•••••
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shrink Hard-to-Treat salivary gland tumors?
- Can a targeted drug shrink rare salivary gland tumors?
- New drug cocktail targets genetic weakness in rare cancer
- Drug duo takes on rare head and neck tumors
- Rare sinus cancer study aims to clarify treatment outcomes
- New pill-chemo combo takes on hard-to-treat cancers